Uterine Corpus Sarcoma — Trials

Uterine Corpus Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 22
Ph III recruiting: 4
Growth YoY: —
Industry share: 15%
Top sponsor: Assistance Publique Hopitaux De Marseille
Termination share: 24.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06524583	Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour(L-UteCIN)	recruiting	Phase 2	198	UNICANCEROTHER	1	Sep 29, 2026	clinicaltrials
NCT03400826	Effects of Simvastatin on Uterine Leiomyoma Size	active not recruiting	Phase 2	60	Johns Hopkins UniversityOTHER	1	Jul 21, 2026